$158,000 ALS drug pulled from market after failing in large clinical trial

The drug is now unavailable to new patients; its maker to lay off 70% of employees.

By: Ars Technica

Apr 17 2024
34
3868 Views

$158,000 ALS drug pulled from market after failing in large clinical trial — $158,000 ALS drug pulled from

3 Amylyx, the maker of a new drug to treat ALS, is pulling that drug from the market and laying off 70 percent of its workers after a large clinical trial found that the drug did not help patients, … [+2338 chars]

The insane chain of events that decided Rangers' playoff opponent

Russian diplomat says US didn’t pass along ‘concrete’ info before attack

Study finds deadly bacteria with ‘thirst for human blood’

Capitals make playoffs, thank Flyers for odd open-net winner

FanDuel launches in Washington D.C.

UN envoy: U.S., allies seeking new ways to monitor sanctions on North Korea

Shohei Ohtani ‘Can do Better’ Says Dave Roberts; Dodgers Manager Criticises Recent Mediocre Performances

Supreme Court gives some military veterans more generous educational benefits

New York Students to Hear from NASA Astronaut Aboard Space Station

Watch Fed Chair Powell speak live during a policy forum in Washington

NFL Draft 2024: Jayden Daniels Currently Top Choice for Dan Quinn & Commanders, Says NFL Insider

Capitals clinch playoff berth with unusual empty net goal

Share this page

Guest Posts by Easy Branches

Nourishing the Mind: The Role of Nutrition and Exe

Introducing AI and Machine Learning to Kids

Navigating the Globe with eSIM: Effortless Travel

all our websites